113 related articles for article (PubMed ID: 14561992)
1. Autografting as a risk factor for persisting iron overload in long-term survivors of acute myeloid leukaemia.
Butt NM; Clark RE
Bone Marrow Transplant; 2003 Nov; 32(9):909-13. PubMed ID: 14561992
[TBL] [Abstract][Full Text] [Related]
2. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
[TBL] [Abstract][Full Text] [Related]
3. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
Kim YR; Kim JS; Cheong JW; Song JW; Min YH
Acta Haematol; 2008; 120(3):182-9. PubMed ID: 19129689
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of phlebotomy to reduce transfusional iron overload in adult, long-term survivors of acute leukemia.
Franchini M; Gandini G; Veneri D; de Matteis G; Federici F; Solero P; Aprili G
Transfusion; 2004 Jun; 44(6):833-7. PubMed ID: 15157247
[TBL] [Abstract][Full Text] [Related]
5. Iron overload in hematopoietic cell transplantation.
Majhail NS; Lazarus HM; Burns LJ
Bone Marrow Transplant; 2008 Jun; 41(12):997-1003. PubMed ID: 18438425
[TBL] [Abstract][Full Text] [Related]
6. Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation.
Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Yağci M
Transplant Proc; 2010 Jun; 42(5):1841-8. PubMed ID: 20620535
[TBL] [Abstract][Full Text] [Related]
7. Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation.
Chotsampancharoen T; Gan K; Kasow KA; Barfield RC; Hale GA; Leung W
Pediatr Transplant; 2009 May; 13(3):348-52. PubMed ID: 18518909
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors.
Majhail NS; Lazarus HM; Burns LJ
Biol Blood Marrow Transplant; 2010 Jun; 16(6):832-7. PubMed ID: 20079863
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.
Majhail NS; DeFor T; Lazarus HM; Burns LJ
Biol Blood Marrow Transplant; 2008 Jul; 14(7):790-4. PubMed ID: 18541198
[TBL] [Abstract][Full Text] [Related]
10. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
[TBL] [Abstract][Full Text] [Related]
11. Autologous stem cell transplantation in acute myeloid leukemia. Factors influencing outcome. A 13 year single institution experience.
Martins C; Lacerda JF; Lourenço F; Carmo JA; Lacerda JM
Acta Med Port; 2005; 18(5):329-37. PubMed ID: 16611537
[TBL] [Abstract][Full Text] [Related]
12. Transfusion-associated iron overload as a predictive factor for poor stem cell mobilization in patients with haematological malignancies.
Park IH; Kim Y; Kim JS; Cheong JW; Song JW; Min YH
Transfus Med; 2008 Apr; 18(2):97-103. PubMed ID: 18399843
[TBL] [Abstract][Full Text] [Related]
13. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.
Chacko J; Pennell DJ; Tanner MA; Hamblin TJ; Wonke B; Levy T; Thomas PW; Killick SB
Br J Haematol; 2007 Sep; 138(5):587-93. PubMed ID: 17610536
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome after intensive therapy with etoposide, melphalan, total body irradiation and autotransplant for acute myeloid leukemia.
Mollee P; Gupta V; Song K; Reddy V; Califaretti N; Tsang R; Crump M; Keating A
Bone Marrow Transplant; 2004 Jun; 33(12):1201-8. PubMed ID: 15094745
[TBL] [Abstract][Full Text] [Related]
15. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.
Fung EB; Harmatz P; Milet M; Ballas SK; De Castro L; Hagar W; Owen W; Olivieri N; Smith-Whitley K; Darbari D; Wang W; Vichinsky E;
Am J Hematol; 2007 Apr; 82(4):255-65. PubMed ID: 17094096
[TBL] [Abstract][Full Text] [Related]
16. Autologous stem cell transplantation in the treatment of adults with acute myeloid leukaemia.
Breems DA; Löwenberg B
Br J Haematol; 2005 Sep; 130(6):825-33. PubMed ID: 16156852
[TBL] [Abstract][Full Text] [Related]
17. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Kataoka K; Nannya Y; Hangaishi A; Imai Y; Chiba S; Takahashi T; Kurokawa M
Biol Blood Marrow Transplant; 2009 Feb; 15(2):195-204. PubMed ID: 19167679
[TBL] [Abstract][Full Text] [Related]
18. Is there a plateau in the survival curve after autologous transplantation in patients with intermediate and high-risk acute myeloid leukemia? A 20-year single institution experience.
Ganguly S; Singh J; Divine CL; Deauna-Limayo D; Bodensteiner DC; Lewis JL; Curran K; Skikne BS
Leuk Res; 2007 Sep; 31(9):1253-7. PubMed ID: 17320953
[TBL] [Abstract][Full Text] [Related]
19. FLT3 mutations in normal karyotype acute myeloid leukemia in first complete remission treated with autologous peripheral blood stem cell transplantation.
Yoshimoto G; Nagafuji K; Miyamoto T; Kinukawa N; Takase K; Eto T; Kato K; Hayashi S; Kamimura T; Ohno Y; Taniguchi S; Harada M
Bone Marrow Transplant; 2005 Dec; 36(11):977-83. PubMed ID: 16184177
[TBL] [Abstract][Full Text] [Related]
20. Iron Overload in Survivors of Childhood Cancer.
Schempp A; Lee J; Kearney S; Mulrooney DA; Smith AR
J Pediatr Hematol Oncol; 2016 Jan; 38(1):27-31. PubMed ID: 26422286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]